94 results
Page 2 of 5
6-K
EX-99.1
kvof10162f2fvvzn
7 Feb 22
Current report (foreign)
2:40pm
6-K
EX-99.1
617 z0bf4xl1q26yc6d1
27 Jan 22
Galapagos appoints Paul Stoffels as Chief Executive Officer
12:00am
6-K
EX-99.1
yxrwm70p94393n yvq3a
19 Jan 22
Jyseleca®▼ (Filgotinib) Licensed for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis In Great Britain
11:37am
6-K
EX-99.1
opierdr
29 Nov 21
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
6:00am
6-K
EX-99.1
r1bko2u6mdq
17 Nov 21
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
6:00am
6-K
EX-99.1
dyes4p5xvl6orw6h
6 Oct 21
Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress
6:00am
6-K
EX-99.1
2vynbt113 7h7xzjm
6 Oct 21
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
6:00am
6-K
EX-99.1
njfagun 6yicqm
20 Sep 21
Current report (foreign)
9:26am
6-K
EX-99.1
o7y5q9j9ho
31 Aug 21
Galapagos announces planned retirement of CEO
3:46pm
6-K
EX-99.1
pz0pymb4fy384d5
14 Jul 21
Current report (foreign)
5:27pm
6-K
EX-99.1
h9ft4m9
14 Jul 21
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
5:13pm
6-K
EX-99.1
nzbu4ytd07dyxs4cd9v
12 Jul 21
New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn’s and Colitis Organisation (ECCO) virtual congress
9:02am
6-K
EX-99.1
judy6tyntmziyrsl bxr
23 Jun 21
Galapagos announces departure of CSO Piet Wigerinck later this year
6:00am
6-K
EX-99.1
lui say1vcht
4 Jun 21
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
6:05am
6-K
EX-99.1
ogi8ovcsokvn9f35jhhe
28 May 21
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
6:00am
6-K
EX-99.1
rdxvf2pmnzin
19 May 21
Current report (foreign)
6:00am
6-K
EX-99.3
0wkcs2 wx
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
3yxmd80m1s7mowmm
23 Apr 21
Current report (foreign)
6:05am
6-K
EX-99.1
bxt9l1tunc4uvwbz
9 Apr 21
Extension of lock-up period in Gilead-Galapagos collaboration agreement
6:00am
6-K
EX-99.1
4kyzz9signfh xc
25 Mar 21
Galapagos appoints Bart Filius as President and Chief Operating Officer
6:00am